Skip to main content
SpringerLink
Log in

Nebennierentumoren

  • Chapter
Therapiekonzepte Onkologie

  • 57 Accesses

Zusammenfassung

Histopathologisch ist die Abgrezung eines Nebennierenrindentumors von einem Phäochromozytom am ehesten durch den Nachweis einer negativen Chromogranin A-Färbung möglich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Clemmesen J (1965) Statistical studies in the aetiology of malignant neoplasma. II Munksgaard, Copenhagen. Danish Cancer Registry under National Anti-Cancer League

    Google Scholar 

  2. Bradley L III (1975) Primary and adjunctive therapy in carcinoma of the adrenal cortex. Surg Gynecol Obstet 141: 507

    PubMed  Google Scholar 

  3. Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy 322 (17): 195 —1201

    Google Scholar 

  4. Yano T, Linehan M, Anglard T et al. (1989) Genetic changes in human adrenocortical carcinomas. J N C I 81 (7): 518–523

    CAS  Google Scholar 

  5. Cibas E, Medeiros J, Weinberg D et al. (1990) Cellular DNA Profiles of Benign and Malignant Adrenocortical Tumors 14 (10) :948–955

    CAS  Google Scholar 

  6. Macfarlane D (1958) Cancer of the adrenal cortex. The natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 23: 155–185

    PubMed  CAS  Google Scholar 

  7. Gröndal S, Eriksson B, Hagenäs L et al. (1990) Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endorinol (Copenh) 122: 656–663

    Google Scholar 

  8. Bodie B, Novick A, Pontes E et al. (1989) The Cleveland Clinic experience with adrenal cortical carcinoma. J of Urol 141: 257–260

    CAS  Google Scholar 

  9. Thompson NW (1983) Adrenocortical carcinomas. In: Thompson NW, Vinik AI, (eds) Endocrine Surgery Update, Grane and Stratton, New York

    Google Scholar 

  10. Schteingardt DE, Motazedi A, Noonan RA, Thompson NW (1982) Treatment of adrenal carcinomas. Arch Surg 117: 1142–1146

    Article  Google Scholar 

  11. Lubitz JA, Freeman L, Okun R. Mitotane ause in inoperable adrenal cortical carcinoma. JAMA 223: 1109–1112

    Google Scholar 

  12. Eriksson B, Öberg K, Curstedt T et al. (1987) Treatment of hormone-producing adrenocortical cancer with o.p’DDD and streptozocin 59 (8): 1398–1403

    CAS  Google Scholar 

  13. Flack MR, Pyle RG, Mullen NM et al. (1993) Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 76: 1019–1024

    Article  PubMed  CAS  Google Scholar 

  14. Stein LA, La Rocca R, Thomas R et al. (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncology 7 (4): 499–508

    CAS  Google Scholar 

  15. van Slooten H, Moolenar AJ, van Seters AP, Smeenk F (1984) The treatment of adrenocortical carcinoma with o.p’DDD: prognostic simplications of serum level monitoring Eur J Cancer Clin Oncol 20 (11): 47–53

    Article  Google Scholar 

  16. Tattersall MHN, Lander H, Bain B et al. (1980) Cis-platinum treatment of metastatic adrenal carcinoma. Med J Aust 1: 419–421

    PubMed  CAS  Google Scholar 

  17. Haq M, Legha S, Samaan N et al. (1980) Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep 64: 909–913

    PubMed  CAS  Google Scholar 

  18. van Slooten H, van Oosterom AT (1983) CAP (Cyclophosphamide, Doxorubicin and Cisplatin) Regimen in Adrenal Cortical Carcinoma. Cancer Treat Rep 67 (4): 377–379

    PubMed  Google Scholar 

  19. Johnson D, Greco A (1986) Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16) Cancer 58: 2198–2202

    PubMed  CAS  Google Scholar 

  20. Crocket P, Clark ACL (1989) Combination chemotherapy for adrenal carcinoma: response in a 51/2-year-old male. Medical and Pediatric Oncology 17: 62–65

    Article  Google Scholar 

  21. Schlumberger M, Brugierers L, Gicquel C et al. (1991) 5-Fluorouracil, doxorubine and cisplatin as treatment for adrenal cortical carcinoma. Cancer 67: 2997–3000

    Article  PubMed  CAS  Google Scholar 

  22. Page DL, DeLellis RA, Hough AJ (1986) Tumors of the adrenal. In: Atlas of Tumor Pathology, Washington DC, AFIP

    Google Scholar 

  23. Manager WM, Gifford RW Jr, Hoffman BB (1985) Pheochromocytoma a clinical and experimental overview. Curr Probl Cancer 9: 1

    Google Scholar 

  24. Irvin GL, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94: 938

    PubMed  Google Scholar 

  25. Cryer PE (1985) Pheochromocytoma. Clin Endocrinol Metab 14: 203

    Article  PubMed  CAS  Google Scholar 

  26. Lewis PD (1971) A cytophotometric study of benign and malignant pheochromocytomas. Virchows Arch 9: 371

    CAS  Google Scholar 

  27. Medeiros LJ, Wolf BC, Balogh K et al. (1985) Adreanl pheochromocytoma a clinicopathologic review of 60 cases. Hum Pathol 16: 580

    Article  PubMed  CAS  Google Scholar 

  28. van Heerden JA, Sheps SG, Hamberger B et al. (1982) Pheochromocytoma: current status and changing trends. Surgery 91: 367

    PubMed  Google Scholar 

  29. Bravo EL, Gifford RW Jr (1984) Pheochromocytoma diagnosis, localisation and management. N Engl J Med 311: 1298–1303

    Article  PubMed  CAS  Google Scholar 

  30. Modlin IM, Farndon JR, Shepherd A et al. (1979) Pheochromocytoma in 72 patients: clinial and diagnostic features, treatment and long term results. Br J Surg 66: 456–465

    Article  PubMed  CAS  Google Scholar 

  31. Sheedy PE II, Hattery RR, Stephens DH et al. (1983) Computed tomography of the adrenal gland. In: Hagga JR, Alfidi FJ (eds) Computed Tomography of the whole Body, Vol 2 St Louis C.V. Mosby 681–697

    Google Scholar 

  32. Reinig JW, Doppman JL (1986) Magnetic resonance imaging of the adrenal. Radiologe 26: 186

    PubMed  CAS  Google Scholar 

  33. Shapiro B, Copp JE, Sisson JC et al. (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26: 576

    PubMed  CAS  Google Scholar 

  34. Ross EJ, Richard BNC, Kaufmann L et al. (1969) Preoperative and operative management of patients with pheochromocytoma: Anesth Ana1g Reanimatol 59: 154–162

    Google Scholar 

  35. Shapiro B, Sisson JC, Wieland DM (1991) Radiopharmaceutical therapy of malignant pheochromocytoma with I131 metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 35: 269–276

    PubMed  CAS  Google Scholar 

  36. Lumbroso J, Schlumberger M, Tenenbaum F et al. (1991) I131-metaiodobenzylguanidine therapy in 10 patients with malignant pheochromocytoma. J Nucl Biol Med 35: 288–291

    PubMed  CAS  Google Scholar 

  37. Krempf F, Lumbroso J, Mornex R et al. (1991) Treatment of malignant pheochromocytoma with I131 metaidobenzylguanidine: a French multicenter study. J Nucl Biol Med 35: 284–287

    PubMed  CAS  Google Scholar 

  38. Troncone L, Ruffini V, Daidone MS et al. (1991) I131-metaidobenzylguanidine treatment of malignant pheochromocytoma: experience of the Roma group

    Google Scholar 

  39. Keiser H, Goldstein DS, Wade JL et al. (1985) Treatment of malignant pheochromocytoma with combination chemotherapy: Hypertension I-18–24

    Google Scholar 

  40. Averbuch SD, Steakley CR, Young RC et al. (1988) Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, Vincristine and Dacarbazine. Ann Int Med 109: 267–273

    Article  PubMed  CAS  Google Scholar 

  41. Feldman JM (1983) Treatment of metastatic pheochromocytoma with streptozocin. Arch Int Med 143: 1799–1800

    Article  CAS  Google Scholar 

Download references

Authors
  1. B. Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Öberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung) Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Eriksson, B., Öberg, K. (1995). Nebennierentumoren. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10494-1_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58586-2

  • Online ISBN: 978-3-662-10494-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation